Quick start experiments and flexible experimental design help you to speed up your decisions and lower your research cost.
Medicilon owns 50,000 square meters of R & D laboratories and high-end equipments. Our labs are certified by Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and meet the GLP standard of US FDA and CFDA. Our reclinical safety evaluations also meet the Organization for Economic Cooperation and Development in Europe (OECD) GLP requirements.
Medicilon is the first CRO to offer preclinical animal testing service for the global pharmaceutical companies in China. Some of the platform provided by Medicilon such as Drugs Safety Evaluation for Non-Human Primates Services Platform and Isotope Drug Metabolism Professional Services Platform is certified by Shanghai government. In addition, our platform is certified and identified as an important drug discovery platform by Shanghai government.